F. Çay

发表

Two dose levels of ifosfamide in malignant mesothelioma.

S. Akyar, H. Akbulut, B. Kurt, 1996, Lung cancer.

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

H. Akbulut, A. Demirkazık, F. Içli, 1997, Journal of surgical oncology.

Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.

A. Arıcan, H. Akbulut, A. Demirkazık, 1999, American journal of clinical oncology.

Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine, prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma.

A. Arıcan, H. Akbulut, A. Demirkazık, 1995, Acta oncologica.

A comparison of imipenem monotherapy versus cefoperazonelsulbactam plus amikacin combination treatment in febrile neutropenic cancer patients

A. Arıcan, A. Willke, F. Aydın, 1998 .

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer

B. Yalcin, H. Akbulut, A. Demirkazık, 2007, Journal of surgical oncology.

Results of intensified therapy in acute lymphoblastic leukemia in adults

A. Demirkazık, F. Içli, H. Karaoǧuz, 1994 .

'Carcinoma erysipeloides': Skin Metastasis of Internal Malignancies via Cutaneous Lymphatics.

R. Anadolu, T. Çalikoglu, A. Boyvat, 1999 .

Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

A. Arıcan, H. Akbulut, A. Demirkazık, 1999, Oncology.